Dexamethasone for Cancer-Related Fatigue
Author(s) -
Michael Franco,
Leeroy William,
Peter Poon,
Arun Azad
Publication year - 2014
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2013.53.7878
Subject(s) - medicine , dexamethasone , cancer related fatigue , cancer , oncology
REFERENCES 1. Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al: Reduction of cancerrelated fatigue with dexamethasone: A double-blind, randomized, placebocontrolled trial in patients with advanced cancer. J Clin Oncol 31:3076-3082, 2013 2. Bruera E, Roca E, Cedaro L, et al: Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 69:751-754, 1985 3. Metz CA, Robustelli Della Cuna GR, Pellegrini A, et al: Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled, multicenter study. Eur J Cancer Clin Oncol 25:1817-1821, 1989 4. Bruera E, Neumann C: Management of specific symptom complexes in patients receiving palliative care. Can Med Assoc J 158:1717-1726, 1998 5. Pilkey J, Streeter L, Beel A, et al: Corticosteroid-induced diabetes in palliative care. J Palliat Med 15:681-689, 2012
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom